浙江万丰化工股份有限公司 特定股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603172 证券简称：万丰股份 公告编号：2025-022 上述减持主体无一致行动人。 二、减持计划的实施结果 重要内容提示： 特定股东的基本情况 本次减持计划实施前，舟山瑞好股权投资有限公司（以下简称"舟山瑞好"） 持有浙江万丰化工股份有限公司（以下简称"公司"）无限售条件流通股 5,000,000 股，占公司总股本的 3.75%，属于公司特定股东。上述股份来源 为公司首次公开发行股票并上市前已有的股份。 减持计划的实施结果情况 2025 年 7 月 25 日，公司披露《浙江万丰化工股份有限公司关于特定股东 减持股份计划公告》（公告编号：2025-021）：舟山瑞好计划以大宗交易方 式减持公司股份不超过 2,667,600 股，即不超过公司总股本的 2.00%；自 减持计划公告之日起十五个交易日后的 90 天内（2025 年 8 月 15 日至 2025 年 11 月 12 日）进行。截至本公告日，舟山瑞 ...

万丰股份8月18日晚间发布公告称，截至本公告日，舟山瑞好已通过大宗交易方式减持公司股份约267万 股，占公司总股本2%，减持计划实施完毕。 （文章来源：每日经济新闻） ...

Core Viewpoint - Small-cap stocks exhibit higher volatility and activity compared to large-cap stocks, making them more likely to become market leaders in trends [1]. Group 1: Market Overview - As of August 11, there are 994 stocks with a circulating market value below 3 billion yuan, and 406 stocks with a circulating market value below 2 billion yuan [1]. - A total of 1,664 stocks have a total market value below 5 billion yuan, with 577 stocks having a total market value below 3 billion yuan [1]. Group 2: Small-Cap Stocks - The three stocks with the smallest circulating market values are *ST Zitian at 440 million yuan, Liren Technology at 611 million yuan, and Bofei Electric at 645 million yuan [1]. - The three stocks with the smallest total market values are *ST Zitian at 444 million yuan, *ST Yuancheng at 739 million yuan, and *ST Suwu at 761 million yuan [1]. Group 3: Stock Data Summary - A detailed list of stocks with circulating market values below 2 billion yuan includes: - *ST Zitian: Circulating market value 440 million yuan, total market value 444 million yuan, P/E ratio 39.34, industry: Media [1]. - Liren Technology: Circulating market value 611 million yuan, total market value 2.052 billion yuan, P/E ratio 242.08, industry: Home Appliances [1]. - Bofei Electric: Circulating market value 645 million yuan, total market value 2.825 billion yuan, P/E ratio 164.52, industry: Basic Chemicals [1]. - Additional stocks include Kuntai Co. at 659 million yuan, *ST Qingyan at 667 million yuan, and others with varying market values and P/E ratios [1][2].

Group 1 - Leshan Electric achieved operating revenue of 1.623 billion yuan, a year-on-year increase of 1.94%, and a net profit of 7.9031 million yuan, a year-on-year decrease of 14.55% [1] - Zhimingda reported operating revenue of 295 million yuan, a year-on-year increase of 84.83%, and a net profit of 38.3 million yuan, a year-on-year increase of 2147.93% [2] - Dahu Co. reported operating revenue of 426 million yuan, a year-on-year decrease of 14.40%, and a net loss of 2.5716 million yuan, an improvement from a loss of 13.7824 million yuan in the same period last year [3] - Yubang Electric expects a net profit of 21.2 million to 25 million yuan, a year-on-year decrease of 35.47% to 45.28% [4] - Zhejiang Securities achieved operating revenue of 6.512 billion yuan, a year-on-year decrease of 18.60%, and a net profit of 1.149 billion yuan, a year-on-year increase of 46.54% [5] - Huashu Media reported operating revenue of 4.435 billion yuan, a year-on-year increase of 2.07%, and a net profit of 254 million yuan, a year-on-year increase of 4.63% [7] Group 2 - Sinopec reported oil and gas equivalent production of 262.81 million barrels, a year-on-year increase of 2%, and crude oil processing volume of 119.97 million tons, a year-on-year decrease of 5.3% [8] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS8179, aimed at reducing brain edema after stroke [8] - Hengrui Medicine's subsidiary also received approval for clinical trials of HRS-1893, intended for treating heart failure with preserved ejection fraction [8] - Wanfu Co. announced a plan to reduce its stake by up to 2% through block trading [10] - Biological Co. received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inaccuracies in financial reporting [11] - Zhujiang Co. reported a signed construction area of 47.1432 million square meters across 396 projects [13] Group 3 - Watson Bio received a patent for a peptide delivery system for RNA drugs [15] - Sanwei Chemical signed 31 new contracts worth 335 million yuan in the second quarter [17] - Shenzhou Cell's SCT640C injection received approval for clinical trials for rheumatoid arthritis [18] - Xinjiang Jiaojian reported new contracts worth 1.434 billion yuan in the second quarter [19] - Lais Information plans to use 550 million yuan of idle funds for cash management [21] - Zhongqi New Materials signed a mining rights transfer contract, increasing production capacity [22] Group 4 - Hengtong Optic-Electric won multiple marine energy projects worth 1.509 billion yuan [24] - China State Construction signed new contracts totaling 2.501 trillion yuan in the first half of the year [26] - David Medical's ventilator product registration application has been accepted [28] - Tianhai Defense's subsidiary signed a construction contract worth 16.224 million yuan [29] - Nantian Information plans to sign a procurement framework contract worth 58.27 million yuan with its controlling shareholder [31] - Baida Group announced a plan to reduce its stake by up to 3% [32] Group 5 - Jinli Permanent Magnet plans to issue $117.5 million in convertible bonds [34] - Haizheng Pharmaceutical's fumarate bedaquiline raw material drug application has been approved [36] - Huatai passed the advanced intelligent factory re-evaluation in Anhui Province [37] - Everbright Bank's shareholder increased its stake from 7.08% to 8% [40] - Supor reported total operating revenue of 11.478 billion yuan, a year-on-year increase of 4.68%, and a net profit of 940 million yuan, a year-on-year decrease of 0.07% [41] - Qianjin Pharmaceutical's subsidiaries received registration certificates for two drugs [42]

重要内容提示： 浙江万丰化工股份有限公司 关于特定股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603172 证券简称：万丰股份 公告编号：2025-21 | 股东名称 | 舟山瑞好 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | √否 | | | 直接持股 5%以上股东 | □是 | √否 | | | 董事、监事和高级管理人员 | □是 | √否 | | | 其他：5%以下股东 | | | | 持股数量 | 5,000,000股 | | | | 持股比例 | 3.75% | | | | 当前持股股份来源 | IPO 前取得：5,000,000股 | | | 一、减持主体的基本情况 1 股东持股的基本情况：截至本公告披露日，浙江万丰化工股份有限公 司（以下简称"公司"）股东舟山瑞好股权投资有限公司（曾用名"宁 波瑞好投资有限公司"，以下简称"舟山瑞好"）持有公司无限售条件 流通股 5,000,000 股（占 ...

Core Viewpoint - The company announced that its shareholder, Zhoushan Ruihao, plans to reduce its stake by up to 2% of the total share capital through block trading due to personal funding needs [1] Summary by Relevant Sections - **Shareholder Reduction Plan** - Zhoushan Ruihao intends to sell no more than 2.6676 million shares, which represents up to 2% of the company's current total share capital [1] - Zhoushan Ruihao currently holds 5 million shares, accounting for 3.75% of the total share capital [1] - **Implementation Timeline** - The reduction plan will be executed within 90 days after the announcement, specifically from August 15, 2025, to November 12, 2025 [1] - **Impact on Company** - The company will urge the shareholder to comply with the reduction regulations and fulfill information disclosure obligations [1] - This reduction plan is not expected to have a significant impact on the company's governance structure or future operations [1]

[Core Summary of Performance Forecast](index=1&type=section&id=Important%20Content%20Reminder) The company anticipates a net profit attributable to shareholders of **22 to 26 million yuan** for H1 2025, a **67.72% to 98.21%** increase, with non-recurring net profit expected at **21.3 to 25.3 million yuan**, growing **67.34% to 98.76%**, driven by enhanced profitability | Indicator | 2025 H1 Estimate (Million Yuan) | Increase from Prior Year (Million Yuan) | Year-over-Year Growth | | :--- | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | 22.00 - 26.00 | 8.8828 - 12.8828 | 67.72% - 98.21% | | **Non-recurring Net Profit Attributable to Shareholders** | 21.30 - 25.30 | 8.5711 - 12.5711 | 67.34% - 98.76% | [Details of Current Period Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast) This report details the performance forecast for January 1 to June 30, 2025, projecting significant growth in both net profit attributable to shareholders and non-recurring net profit, based on preliminary unaudited estimates - The performance forecast covers the period from January 1 to June 30, 2025[3](index=3&type=chunk) | Indicator | 2025 H1 Estimate (Million Yuan) | Year-over-Year Growth | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | 22.00 - 26.00 | 67.72% - 98.21% | | **Non-recurring Net Profit Attributable to Shareholders** | 21.30 - 25.30 | 67.34% - 98.76% | - The company explicitly states that this performance forecast is a preliminary estimate and has not been audited by a certified public accountant[4](index=4&type=chunk) [Prior Period Performance Review](index=2&type=section&id=II.%20Operating%20Performance%20and%20Financial%20Status%20in%20Prior%20Period) The report reviews H1 2024 financial data as a comparative baseline, with net profit attributable to shareholders at **13.1172 million yuan**, non-recurring net profit at **12.7289 million yuan**, and EPS at **0.10 yuan**, providing a low base for current period growth | Indicator (2024 H1) | Amount/Value | | :--- | :--- | | Total Profit | 15.7719 Million Yuan | | Net Profit Attributable to Shareholders | 13.1172 Million Yuan | | Non-recurring Net Profit Attributable to Shareholders | 12.7289 Million Yuan | | Earnings Per Share | 0.10 Yuan/Share | [Analysis of Performance Increase Reasons](index=2&type=section&id=III.%20Primary%20Reasons%20for%20Current%20Period%20Performance%20Increase) Significant H1 2025 performance growth is primarily attributed to successful international market expansion, effective cost reduction and efficiency improvement measures, and a lower comparative base from the prior year, collectively boosting sales and gross margin - Key drivers for performance growth include: - **International Market Expansion**: Successful overseas market development, product alignment with customer needs, and tariff policy impacts led to significant growth in international sales[6](index=6&type=chunk) - **Cost Control**: The company continuously implemented cost reduction and efficiency improvement measures, enhancing operational efficiency and driving overall gross margin growth[6](index=6&type=chunk) - **Low Base Effect**: A smaller comparative base from the prior year amplified the current period's performance increase[6](index=6&type=chunk) [Risk Warning and Other Notes](index=2&type=section&id=IV.%20Risk%20Warning) The company warns that this performance forecast is a preliminary, unaudited financial estimate, which may differ from the final semi-annual report, and while no major uncertainties affecting accuracy are currently identified, investors are advised to consider investment risks - This performance forecast is based on preliminary, unaudited data, and the final accurate financial figures will be subject to the company's officially disclosed 2025 semi-annual report[7](index=7&type=chunk)[8](index=8&type=chunk) - The company states that as of the announcement date, there are no significant uncertainties affecting the accuracy of this performance forecast[7](index=7&type=chunk)

Summary of Key Points Core Viewpoint - Ningbo Yixian Enterprise Management Consulting Co., Ltd. has completed its share reduction plan for Zhejiang Wanfeng Chemical Co., Ltd., reducing its holdings by 2,332,400 shares, which is 1.75% of the total share capital [1][2]. Group 1: Shareholder Information - Ningbo Yixian held 2,332,400 shares before the reduction, representing 1.75% of the total share capital, with shares acquired prior to the company's IPO [1][2]. - The shareholder does not have any concerted actions with other parties [2]. Group 2: Reduction Plan Implementation - The reduction plan was announced on May 20, 2025, and the shares were reduced through block trading from June 11, 2025, to September 8, 2025 [2]. - The total amount from the share reduction was approximately 31,930,556 yuan, with a share price range of 13.69 yuan per share [2]. - The reduction plan was fully executed, and the actual reduction matched the previously disclosed plan [2].

证券代码：603172 证券简称：万丰股份 公告编号：2025-019 浙江万丰化工股份有限公司 特定股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 特定股东的基本情况 本次减持计划实施前，宁波怡贤企业管理咨询有限公司（以下简称"宁波 怡贤"）持有浙江万丰化工股份有限公司（以下简称"公司"）无限售条件 流通股 2,332,400 股，占公司总股本的 1.75%，属于公司特定股东。上述 股份来源为公司首次公开发行股票并上市前已有的股份。 减持计划的实施结果情况 | 股东名称 | 宁波怡贤 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | √否 | | | 直接持股 5%以上股东 | □是 | √否 | | | 董事、监事和高级管理人员 | □是 | √否 | | | 其他：5%以下股东 | | | 一、减持主体减持前基本情况 2025 年 5 月 20 日，公司披露《浙江万丰化工股份有限公司关于特定股东 减 ...

Core Points - Wan Feng Co., Ltd. (万丰股份) reported a closing price of 15.21 yuan as of June 13, 2025, down 1.74% from the previous week [1] - The company's total market capitalization is 2.029 billion yuan, ranking 159th out of 169 in the chemical products sector and 4912th out of 5150 in the A-share market [1] Shareholder Changes - As of June 10, 2025, the number of shareholders increased to 9,854, an increase of 1,194 shareholders or 13.79% compared to May 30 [1][3] - The average number of shares held per shareholder decreased from 15,400 shares to 13,500 shares, with an average holding value of 213,900 yuan [1] Company Announcements - Wan Feng Co., Ltd. announced a cash dividend of 0.09 yuan per share (before tax), with the record date set for June 13, 2025, and the payment date on June 16, 2025 [1][3] - The total cash dividend distribution amounts to 12,004,200 yuan based on the company's total share capital of 133,380,000 shares [1] - Different tax treatments apply for various categories of shareholders, with a 10% withholding tax for certain shareholders and exemptions for long-term holders [1]